Ernexa Therapeutics Inc. (ERNA) › Cost of RevenueErnexa Therapeutics Inc. (ERNA) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2022: $02023: $236.0K2024: $96.0K$96.0K2022Cost of Revenue (USD)2024Fiscal YearCost of RevenueChange YoY2024$96.0K-59.3%2023$236.0K—2022$0—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share